Centessa Pharmaceuticals (CNTA) Net Cash Flow: 2022-2025
Historic Net Cash Flow for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to $7.1 million.
- Centessa Pharmaceuticals' Net Cash Flow fell 97.38% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$345.1 million, marking a year-over-year decrease of 252.82%. This contributed to the annual value of $254.0 million for FY2024, which is 195.39% up from last year.
- Per Centessa Pharmaceuticals' latest filing, its Net Cash Flow stood at $7.1 million for Q3 2025, which was up 111.63% from -$60.8 million recorded in Q2 2025.
- Centessa Pharmaceuticals' Net Cash Flow's 5-year high stood at $269.6 million during Q3 2024, with a 5-year trough of -$276.5 million in Q1 2025.
- In the last 3 years, Centessa Pharmaceuticals' Net Cash Flow had a median value of -$14.8 million in 2024 and averaged -$31.1 million.
- In the last 5 years, Centessa Pharmaceuticals' Net Cash Flow skyrocketed by 934.45% in 2024 and then tumbled by 2,656.93% in 2025.
- Over the past 4 years, Centessa Pharmaceuticals' Net Cash Flow (Quarterly) stood at -$51.9 million in 2022, then climbed by 17.25% to -$43.0 million in 2023, then skyrocketed by 65.47% to -$14.8 million in 2024, then tumbled by 97.38% to $7.1 million in 2025.
- Its Net Cash Flow stands at $7.1 million for Q3 2025, versus -$60.8 million for Q2 2025 and -$276.5 million for Q1 2025.